Limulus Amebocyte Lysate (LAL) Can Now Be Produced Without Harvesting the Blood of ~800,000 Horseshoe Crabs Each Year, Which Will Help Restore Their Natural Population
Read Press ReleaseBaltimore-based biotechnology leader, Elixirgen Scientific, Inc., achieves ISO 9001:2015 Quality Management System certification, strengthening commitment to quality, excellence in biotechnology and drug discovery.
Read Press ReleasePA-based clinical technology provider assisTek has announced new features to its upcoming software release, including AI Integration, a Proprietary OS, SSO & Remote Provisioning, to add to its growing suite of eCOA & ePRO solutions.
Read Press ReleaseIn a clinical validation study published on Scientific Reports, UNITY RhD NIPT and Fetal antigen NIPT demonstrated 100% sensitivity, 100% specificity, 99.9% precision with 0.1% no-call rate across 3,921 NIPT assays.
Read Press ReleasePivotal acquisition in Envision Pharma Group's tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products' path to market and ultimately supports the delivery of enhanced patient outcomes.
Read Press ReleaseIn vitro antimicrobial resistance test enables clinical labs to deliver targeted therapeutic results days faster than the current standard of care, clearing the path for personalized antibiotic therapies
Read Press ReleaseComing in overall at 125th, Apprentice is recognized for its 1,159% revenue growth as it continues to scale its Tempo Manufacturing Cloud platform for Life Sciences.
Read Press ReleaseDr. Lewis, PharmD, FIDSA, is one of the preeminent experts in antibiotic stewardship and susceptibility testing (AST). He brings a wealth of knowledge to Selux as the company transforms infectious diseases clinical care and preserves the lifesaving power of antibiotics with its Next Generation Phenotyping (NGP) platform.
Read Press ReleaseGerman-based biotechnology company BioNTech will establish a clinical scale research mRNA manufacturing facility in Australia, following an in-principle letter of intent signed with the Victorian Government.
Read Press Release